Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
William F Feehery is CHIEF EXECUTIVE OFFICER at West Pharmaceutical Services. OQRO lists 2 transactions filed with the SEC under this name, the latest on May 6, 2026, each linked to the official Form 4.
CHIEF EXECUTIVE OFFICER
Disclosures on record
2
Companies involved
2
1 buy, median −20.6 pts vs S&P 500, beat it 0 of 1 time.
Average −20.6 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Nov 12, 2025 to Nov 12, 2025, measured from the first close after the filing. Past results, not a forecast.
1 purchase disclosed; 0% of the 1 measured at 90 days finished ahead of the index.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 83 ranked insiders is −6.0 pts (median, against the S&P 500).
West Pharmaceutical ServicesWST
May 4, 2026791disclosed May 6
DetailsOfficial recordCertara, Inc.CERT
Nov 11, 2025Bought~$200Kdisclosed Nov 12
Equal weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
William F Feehery bought shares on the open market in 2025. Sales in 2 of the 6 years since 2021.
William F Feehery reported 1 open-market purchase and 26 sales since 2021; purchases in 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | $200K1×1 trade | — |
| 2022 | — | $7.66M9×9 trades |
| 2021 | — | $24.1M17×17 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
As of the latest filing on , William F Feehery reported holding 2,360,769 shares of Certara, Inc. (CERT), worth about $26.1M at the last close of $11 (Nov 17, 2026). Holdings are also on file at West Pharmaceutical Services (WST); together they are worth about $39.6M.
Certara, Inc.'s proxy statement reports total compensation of $6.49M for William F Feehery for fiscal year 2025. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Apr 3, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Certara, Inc. CERT | 2,360,769 | 2.36M direct | $11 | $26.1M | Nov 11, 2025 |
| West Pharmaceutical Services WST | 32,519 | 33K direct | $414 | $13.5M | May 4, 2026 |
Is this William F Feehery’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Nov 11, 2025, William F Feehery reported holding 2,360,769 shares of Certara, Inc. (CERT). At the last close of $11 on Nov 17, 2026, that is about $26.1M. This is the stake disclosed in filings, not a net worth.
Certara, Inc.'s proxy statement reports total compensation of $6.49M for William F Feehery for fiscal year 2025. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
William F Feehery bought shares on the open market in 2025. Sales in 2 of the 6 years since 2021.
In SEC filings since 2021: the latest open-market purchase is from 2025; the latest open-market sale is from 2022.
Certara, Inc. (CERT), from 2021 to 2025: 1 purchase and 26 sales.
William F Feehery reported 1 open-market purchase and 26 sales here, 2021 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.